Clinical trial with a genetically modified human adenovirus COVID-19 vaccine
DIR 155, DIR 139, DIR 138 and DIR 127 annual reports.
DIR157, DIR145, DIR143, DIR 124, DIR 118, DIR 091, DIR 066 and DIR 062 annual reports.
The Regulator commissioned a report to provide advice on genetically modified organisms (GMOs) (crops) containing multiple herbicide tolerant traits and impacts on herbicide use, herbicide tolerance and herbicide resistance management issues in Australia.
The Regulator commissioned a report to provide advice on genetically modified organisms (GMOs) (crops) containing multiple herbicide tolerant traits and impacts on herbicide use, herbicide tolerance and herbicide resistance management issues in Australia.
Clinical trial with genetically modified E.coli to reduce antibiotic resistance
Commercial release of Indian mustard genetically modified for herbicide tolerance (RF3)
This Communiqué covers matters considered at the 29th videoconference of the Gene Technology Technical Advisory Committee (28 February 2022).
These guidelines contain the requirements and conditions for certification of a Physical Containment Level 2 (PC2) Large Scale Facility issued pursuant to section 90 of the Gene Technology Act 2000 (the Act).